CBR1 and Dravet syndrome: In this study, we used a transgenic murine model of Cbr1 deletion, as well as pharmacological inhibition of CBR1 in a murine model of DS, to address the hypothesis that CBR1/Cbr1 plays a role in blood pressure regulation and that dysregulation of CBR1 contributes to hypotension in DS.